Real-world outcomes in patients with AML and MDS treated with Azacitidine

被引：0
|
作者：
Prusak, E. [1 ]
Lawes, M. [2 ]
Collins, A. [2 ]
机构：
[1] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[2] Norfolk & Norwich Univ Hosp, Haematol, Norwich, Norfolk, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
AML; Azacitidine; mds;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-PO-0
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [11] INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HIGH-RISK MDS AND AML TREATED WITH AZACITIDINE
    Pomares Marin, H.
    Arnan Sangerman, M.
    Sanchez-Ortega Sanchez, I.
    Duarte Palomino, R. D.
    LEUKEMIA RESEARCH, 2015, 39 : S145 - S146
  • [12] OUTCOME OF AZACITIDINE TREATMENT AND INCIDENCE OF FEBRILE EVENTS IN "REAL WORLD" PATIENTS WITH MDS OR LOW-BLAST COUNT AML
    Voso, M. T.
    Niscola, P.
    Piciocchi, A.
    Fianchi, L.
    Maurillo, L.
    Musto, P.
    Pagano, L.
    Mansueto, G.
    Criscuolo, M.
    Aloe-Spiriti, M. A.
    Buccisano, F.
    Venditti, A.
    Tendas, A.
    Piccioni, A. L.
    Zini, G.
    Latagliata, R.
    Filardi, N.
    Fragasso, R.
    Fenu, S.
    Breccia, M.
    LEUKEMIA RESEARCH, 2015, 39 : S99 - S99
  • [13] REAL-WORLD LONG TERM OUTCOMES IN NATALIZUMAB TREATED PATIENTS
    Wynford-Thomas, Ray
    Owen, Helen
    Mulloch, Sue
    Evans, Peter
    Conway, Bernie
    Watson, Lynne
    Pearson, Owen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [14] The real-world outcomes of multiple myeloma patients treated with daratumumab
    Szabo, Agoston Gyula
    Klausen, Tobias Wirenfeldt
    Levring, Mette Boegh
    Preiss, Birgitte
    Helleberg, Carsten
    Breinholt, Marie Fredslund
    Hermansen, Emil
    Gjerdrum, Lise Mette Rahbek
    Bonlokke, Soren Thorgaard
    Nielsen, Katrine
    Kjeldsen, Eigil
    Iversen, Katrine Fladeland
    Teodorescu, Elena Manuela
    Dokhi, Marveh
    Kurt, Eva
    Strandholdt, Casper
    Andersen, Mette Klarskov
    Vangsted, Annette Juul
    PLOS ONE, 2021, 16 (10):
  • [15] Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine
    Cluzeau, Thomas
    Mounier, Nicolas
    Karsenti, Jean-Michel
    Richez, Valentine
    Legros, Laurence
    Gastaud, Lauris
    Garnier, Georges
    Re, Daniel
    Montagne, Nathalie
    Gutnecht, Jean
    Fuzibet, Jean Gabriel
    Auberger, Patrick
    Raynaud, Sophie
    Cassuto, Jill-Patrice
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (09) : 780 - 783
  • [16] Azacitidine in Relapsed and Refractory AML: Efficacy for Patients Relapsing As MDS Post AML
    Ivanoff, Sarah
    Lemasle, Emilie
    Gruson, Berengere
    Merlusca, Lavinia
    Charbonnier, Amandine
    Parcelier, Anne
    Damaj, Gandhi
    Royer, Bruno
    Marolleau, Jean Pierre
    BLOOD, 2012, 120 (21)
  • [17] Azacitidine has limited activity in 'real life' patients with MDS and AML: a single centre experience
    Ozbalak, Murat
    Cetiner, Mustafa
    Bekoz, Huseyin
    Atesoglu, Elif Birtas
    Ar, Cem
    Salihoglu, Ayse
    Tuzuner, Nukhet
    Ferhanoglu, Burhan
    HEMATOLOGICAL ONCOLOGY, 2012, 30 (02) : 76 - 81
  • [18] Real-World Outcomes in Patients with Hereditary Angioedema (HAE) Treated with Berotralstat
    Anderson, John
    Desai, Bhavisha
    Tilley, Alex
    Johnston, Douglas
    Wasilewski, Stephanie
    Banerji, Aleena
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB135 - AB135
  • [19] Optimal Outcomes in Real-World Patients Treated With TEER Reaching the Pinnacle
    Hibbert, Benjamin
    Alkhouli, Mohamad
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (05) : 603 - 605
  • [20] Real-world outcomes in patients with diabetic macular oedema treated with faricimab
    Bedan, Aseel Hamoud
    Palmieri, Filomena
    Younis, Saad
    Ali, Ahmad
    Kurumthottical, Mathew
    Fabozzi, Lorenzo
    Taechameekietichai, Teerajet
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
12345